Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Gastroenterology

Confirming a Diagnosis of Zollinger-Ellison Syndrome

At a Glance

Zollinger-Ellison syndrome is confirmed by interpreting a high fasting gastrin level together with a gastric pH below 2.0; a secretin stimulation test may help when results are uncertain. Never stop a PPI without specialist supervision because acid complications can be dangerous.

Zollinger-Ellison Syndrome (ZES) is a rare condition that occurs when one or more tumors, called gastrinomas, form in your pancreas or the upper part of your small intestine (duodenum) [1]. These tumors release large amounts of a hormone called gastrin, which signals your stomach to produce excessive amounts of acid [2]. This excess acid leads to severe peptic ulcers and chronic diarrhea.

Diagnosing ZES is often a complex process because its symptoms overlap with much more common issues like standard acid reflux (GERD) or typical stomach ulcers [2]. On average, patients experience symptoms for more than five years before receiving a correct diagnosis [2].

The Biochemical Diagnostic Pattern

Because many conditions and medications can cause high gastrin levels, a diagnosis of ZES cannot be made based on a blood test alone [3]. Doctors typically look for a specific confirmatory pattern combining two factors:

  1. Elevated Fasting Serum Gastrin (FSG): Your gastrin levels must be significantly elevated after fasting overnight. A level above 1,000 pg/mL (or greater than 10 times the upper limit of normal) is strongly supportive of ZES [1]. However, many patients have lower elevations, which require expert evaluation to interpret.
  2. Gastric pH < 2.0: This measurement, typically taken during an endoscopy or via a specialized probe, proves that your stomach is highly acidic [1].

If your gastrin is high but your stomach acid is low (a high pH), ZES is unlikely, provided the measurement is valid [3]. Low stomach acid actually triggers the body to produce more gastrin to try and fix the balance—this is a normal response seen in conditions like atrophic gastritis or when taking acid-blocking medications [3][4]. True ZES is “inappropriate” high gastrin: the body keeps pumping out the hormone even though the stomach is already dangerously acidic [3].

The Secretin Stimulation Test

In cases where gastrin levels are elevated but the diagnosis is equivocal, doctors may use the secretin stimulation test [1].

Under normal circumstances, a hormone called secretin tells the stomach to stop producing gastrin. However, gastrinoma cells behave abnormally—they react to secretin by releasing even more gastrin into your bloodstream [1][5]. During this test, a medical professional will give you an intravenous (IV) dose of secretin and draw blood at specific intervals to see if your gastrin levels spike [1].

What the Test Day Involves: You will be asked to fast overnight. A nurse will place an IV line to administer the secretin and draw several blood samples over roughly 30 to 60 minutes. Your specialist will give you exact instructions on whether to take your acid-blocking medications that morning.

The Danger of Stopping PPIs

Proton pump inhibitors (PPIs) like omeprazole, lansoprazole, and pantoprazole are the standard treatment for high stomach acid. However, they complicate the diagnostic process because they naturally raise gastrin levels and lower stomach acid (raising pH) [6][7].

While older protocols suggested stopping PPIs for at least one week before testing, this can be extremely dangerous for someone with suspected ZES [6]. Abruptly stopping these medications can cause recurrent acid hypersecretion, leading to rapid return of severe ulcers, gastrointestinal bleeding, or perforation (a hole in the stomach or intestine) [6][7][8].

Important Safety Note: Never stop or change your PPI dose on your own. Medication management before testing must be decided by an experienced gastroenterologist or neuroendocrine-tumor center. Some centers have validated protocols to perform secretin stimulation tests while you stay on your PPI medication, while others may carefully transition you to an alternative medication (like an H2 blocker) with close monitoring [9].

Why Diagnosis Takes Time

The delay in diagnosing ZES usually happens because the symptoms are so common [2]. ZES is typically only suspected when:

  • Ulcers are unusually severe or keep coming back despite high-dose treatment [2].
  • You have multiple ulcers in unusual locations [2].
  • You have severe diarrhea that improves when taking acid blockers [2].
  • You have a family history of Multiple Endocrine Neoplasia type 1 (MEN1) [6][10].

If ZES is suspected, your care team will use a combination of these blood and acid tests, followed by specialized imaging to locate the small tumors [10].

Common questions in this guide

What tests are used to confirm Zollinger-Ellison syndrome?
Doctors usually confirm suspected Zollinger-Ellison syndrome by finding a very high fasting serum gastrin level together with a gastric pH below 2.0, showing that the stomach is still strongly acidic. A gastrin result by itself is not enough because medicines and other conditions can raise gastrin.
Can a proton pump inhibitor affect my gastrin test?
Yes. Proton pump inhibitors can raise gastrin levels and lower stomach acid, which can make test results harder to interpret. A high gastrin level combined with low stomach acid is usually a different pattern from Zollinger-Ellison syndrome, so your specialist must interpret the results.
What happens during a secretin stimulation test?
You usually fast overnight, receive secretin through an IV, and have several blood samples taken over about 30 to 60 minutes. Gastrinoma cells may release more gastrin after secretin, causing a rise that can support the diagnosis when initial results are uncertain.
Should I stop omeprazole or another PPI before testing for Zollinger-Ellison syndrome?
Do not stop or change your PPI on your own. Suddenly stopping it can cause a dangerous return of excess acid, severe ulcers, bleeding, or a hole in the stomach or intestine. An experienced specialist will choose whether you can stay on the PPI or need a carefully monitored alternative.
Why can Zollinger-Ellison syndrome take a long time to diagnose?
Its symptoms can resemble common acid reflux and ordinary stomach ulcers, so the condition may not be suspected at first. Unusually severe or recurring ulcers, multiple ulcers in unusual locations, or diarrhea that improves with acid-blocking medicine can prompt more specific testing.
Does a family history of MEN1 matter when evaluating Zollinger-Ellison syndrome?
Yes. A family history of Multiple Endocrine Neoplasia type 1, endocrine tumors, or high calcium levels can make doctors more alert to possible gastrinomas and related conditions. This history does not confirm Zollinger-Ellison syndrome, but it is important to share with your care team.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my exact fasting serum gastrin level, and what is the 'normal' range for the laboratory that performed the test?
  2. 2.Was my gastric pH measured at the same time as my gastrin, and was it below 2.0?
  3. 3.If we need to do a secretin stimulation test, what is your center's specific protocol regarding my proton pump inhibitor (PPI)?
  4. 4.If you want me to stop my PPI for testing, what is the step-down plan to prevent ulcer complications, and who do I call if symptoms return?
  5. 5.Have you ruled out other causes of high gastrin, such as atrophic gastritis, H. pylori infection, or kidney issues?
  6. 6.Does our hospital use a specific gastrin assay that is reliable for diagnosing gastrinomas?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.

    Chatzipanagiotou O, Schizas D, Vailas M, et al.

    Journal of neuroendocrinology 2023; (35(4)):e13267 doi:10.1111/jne.13267.

    PMID: 37042078
  2. 2

    Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.

    Rossi RE, Elvevi A, Citterio D, et al.

    World journal of gastroenterology 2021; (27(35)):5890-5907 doi:10.3748/wjg.v27.i35.5890.

    PMID: 34629807
  3. 3

    Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

    Metz DC, Cadiot G, Poitras P, et al.

    International journal of endocrine oncology 2017; (4(4)):167-185 doi:10.2217/ije-2017-0018.

    PMID: 29326808
  4. 4

    Gastric Hypersecretory States: Investigation and Management.

    Phan J, Benhammou JN, Pisegna JR

    Current treatment options in gastroenterology 2015; (13(4)):386-97 doi:10.1007/s11938-015-0065-8.

    PMID: 26342486
  5. 5

    Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome.

    Mendelson AH, Donowitz M

    Digestive diseases and sciences 2017; (62(9)):2258-2265 doi:10.1007/s10620-017-4695-7.

    PMID: 28776139
  6. 6

    Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process.

    Singh Ospina N, Donegan D, Rodriguez-Gutierrez R, et al.

    The American journal of medicine 2017; (130(5)):603-605 doi:10.1016/j.amjmed.2016.11.035.

    PMID: 28011308
  7. 7

    Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient.

    Perrier M, Delemer B, Deguelte S, et al.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2021; (21(1)):236-239 doi:10.1016/j.pan.2020.12.002.

    PMID: 33309626
  8. 8

    Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES.

    Ito T, Ramos-Alvarez I, Jensen RT

    Cancers 2023; (15(5)) doi:10.3390/cancers15051377.

    PMID: 36900170
  9. 9

    Validity of Secretin Stimulation Testing on Proton Pump Inhibitor Therapy for Diagnosis of Zollinger-Ellison Syndrome.

    Bhattacharya S, Blau JE, Cochran C, et al.

    The American journal of gastroenterology 2021; (116(11)):2216-2221 doi:10.14309/ajg.0000000000001487.

    PMID: 34515664
  10. 10

    How to treat gastrinomas in patients with multiple endocrine neoplasia type1: surgery or long-term proton pump inhibitors?

    Imamura M, Komoto I, Taki Y

    Surgery today 2023; (53(12)):1325-1334 doi:10.1007/s00595-022-02627-z.

    PMID: 36473964

This page is for informational purposes only and does not constitute medical advice. Do not stop or change a PPI for Zollinger-Ellison testing without guidance from your gastroenterologist.

Get notified when new evidence is published on Zollinger-Ellison syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.